EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

Glutamate infusion associated with reduced rises of p‐Copeptin after coronary surgery: Substudy of GLUTAMICS II

Rolf Svedjeholm, Gabriele Ferrari iD, Farkas Vanky, Örjan Friberg, Jonas Holm iD

Acta Anaesthesiologica Scandinavica · 2023

DOI: 10.1111/aas.14303 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Acta Anaesthesiologica Scandinavica, 2023. Verfasst von Rolf Svedjeholm und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic and Vascular Surgery, Department of Health, Medicine and Caring Sciences, Unit of Cardiovascular Medicine, Linköping Universit…. Hauptthemen laut MEDLINE: Glutamic Acid, Coronary Artery Bypass, Glycopeptides. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Region Östergötland, Swedish Heart-Lung Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Glutamate plays a key role for post‐ischaemic recovery of myocardial metabolism. According to post hoc analyses of the two GLUTAMICS trials, patients without diabetes benefit from glutamate with less myocardial dysfunction after coronary artery bypass surgery (CABG). Copeptin reflects activation of the Arginine Vasopressin system and is a reliable marker of heart failure but available studies in cardiac surgery are limited. We investigated whether glutamate infusion is associated with reduced postoperative rises of plasma Copeptin (p‐Copeptin) after CABG.

Methods

A prespecified randomised double‐blind substudy of GLUTAMICS II. Patients had left ventricular ejection fraction ≤0.30 or EuroSCORE II ≥3.0 and underwent CABG ± valve procedure. Intravenous infusion of 0.125 M L‐glutamic acid or saline at 1.65 mL/kg/h was commenced 10–20 min before the release of the aortic cross‐clamp and then continued for another 150 min P‐Copeptin was measured preoperatively and postoperatively on day one (POD1) and day three. The primary endpoint was an increase in p‐Copeptin from the preoperative level to POD1. Postoperative stroke ≤24 h and mortality ≤30 days were safety outcomes.

Results

We included 181 patients of whom 48% had diabetes. The incidence of postoperative mortality ≤30 days (0% vs. 2.1%; p = .50) and stroke ≤24 h (0% vs. 3.2%; p = .25) did not differ between the glutamate group and controls. P‐Copeptin increased postoperatively with the highest values recorded on POD1 without significant inter‐group differences. Among patients without diabetes, p‐Copeptin did not differ preoperatively but postoperative rise from preoperative level to POD1 was significantly reduced in the glutamate group (73 ± 66 vs. 115 ± 102 pmol/L; p = .02). P‐Copeptin was significantly lower in the Glutamate group on POD1 ( p = .02) and POD 3 ( p = .02).

Conclusions

Glutamate did not reduce rises of p‐Copeptin significantly after moderate to high‐risk CABG. However, glutamate was associated with reduced rises of p‐Copeptin among patients without diabetes. These results agree with previous observations suggesting that glutamate mitigates myocardial dysfunction after CABG in patients without diabetes. Given the exploratory nature of these findings, they need to be confirmed in future studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glutamic AcidCoronary Artery BypassGlycopeptidesHumansMaleFemaleAgedDouble-Blind MethodMiddle AgedPostoperative ComplicationsInfusions, IntravenousBiomarkers

Stichwörter der Autor:innen

copeptincoronary surgerydiabetesglutamateheart failuremyocardial ischaemiaperioperative care

Substanzen

Glutamic AcidcopeptinsGlycopeptidesBiomarkers

Autor:innen und Institutionen

  • Department of Thoracic and Vascular Surgery, Department of Health, Medicine and Caring Sciences, Unit of Cardiovascular Medicine, Linköping University, Linköping, Sweden.
  • Department of Cardiothoracic and Vascular Surgery, Faculty of Medicine and Health, Health Care Research Centre, Örebro University, Örebro, Sweden.

ORCID-Profile: Gabriele Ferrari, Jonas Holm

Förderung

  • Region Östergötland
  • Swedish Heart-Lung Foundation

Zitieren

APA

Svedjeholm, R., Ferrari, G., Vanky, F., Friberg, Ö., & Holm, J. (2023). Glutamate infusion associated with reduced rises of p‐Copeptin after coronary surgery: Substudy of GLUTAMICS II. Acta Anaesthesiologica Scandinavica. https://doi.org/10.1111/aas.14303

Vancouver

Svedjeholm R, Ferrari G, Vanky F, Friberg Ö, Holm J. Glutamate infusion associated with reduced rises of p‐Copeptin after coronary surgery: Substudy of GLUTAMICS II. Acta Anaesthesiologica Scandinavica. 2023. doi:10.1111/aas.14303

BibTeX
@article{Svedjeholm2023,
  author = {Svedjeholm, Rolf and Ferrari, Gabriele and Vanky, Farkas and Friberg, Örjan and Holm, Jonas},
  title = {Glutamate infusion associated with reduced rises of p‐Copeptin after coronary surgery: Substudy of GLUTAMICS II},
  journal = {Acta Anaesthesiologica Scandinavica},
  year = {2023},
  doi = {10.1111/aas.14303}
}
Kostenlos starten →